Article
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Proceedings of the National Academy of Sciences of the United States of America - 2 Mar 2010
Carén Helena, Kryh Hanna, Nethander Maria, Sjöberg Rose-Marie, Träger Catarina, Nilsson Staffan, Abrahamsson Jonas, Kogner Per, Martinsson Tommy
Abstract excerpt
Analysis of chromosomal aberrations is used to determine the prognosis of neuroblastomas (NBs) and to aid treatment decisions. MYCN amplification (MNA) alone is an incomplete poor prognostic factor, and chromosome 11q status has recently been included in risk classification. We analyzed 165 NB tumors using high-density SNP microarrays and specifically compared the high-risk groups defined by MNA (n = 37) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
